logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
SVRA
Savara Inc.
6.06
2 x 4.52
2 x 7.74
bid
ask
-
0.10
1.62%
2 @ 06:38 AM
5.81 -0.25 (4.13%)
Ytd0.50%
1y188.57%
6.00
day range
6.29
2.03
52 week range
7.00
Open6.13Prev Close6.16Low6.00High6.29Mkt Cap1.24B
Vol1.50MAvg Vol1.56MEPS-0.56P/EN/AForward P/E-20.61
Beta0.27Short Ratio19.82Inst. Own104.22%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-1350-d Avg5.28200-d Avg5.171yr Est10.94

SVRA News

What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline
fool.com
What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline

394,528 shares of Common Stock were sold for about $2.24 million on June 22, 2026, at a weighted ave
benzinga.com
Savara Chief Financial And Administrative Officer Dave Lowrance Stepping Down, Effective July 15; CO

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare
benzinga.com
Savara Presents New Biomarker Data From Double-Blind Period Of IMPALA-2 Phase 3 Clinical Trial Evalu

Savara Inc. (NASDAQ:SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare

benzinga.com
Savara Presents New Exercise Capacity Data From Double-Blind Period Of IMPALA-2 Phase 3 Clinical Tri

-- Data Were Presented in an Oral Presentation at the American Thoracic Society (ATS) International

benzinga.com
Savara Q1 EPS $(0.15) Misses $(0.14) Estimate

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.15) per share which missed the analyst consens
benzinga.com
Savara's MOLBREEVI MAA Accepted By MHRA For Autoimmune PAP, Joining Ongoing FDA And EMA Reviews With

-- MHRA's Acceptance Follows Acceptance/Validation of MOLBREEVI Biologics License Application (B
benzinga.com
Savara Receives European Medicines Agency Validation For Submission Of MOLBREEVI MAA In Autoimmune P

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare
benzinga.com
Savara Q4 EPS $(0.13), Inline

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.13) per share which met the analyst consensus

benzinga.com
Savara Says U.S. FDA Will Not Hold Advisory Panel For MOLBREEVI BLA As Review Continues Toward Augus

-- Day 74 Letter Received from the U.S. Food and Drug Administration (FDA) Indicated the Agency Has

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Meta Platforms To $815? Here Are 10 Top Analyst Forecasts For Tuesday
benzinga.com
Meta Platforms To $815? Here Are 10 Top Analyst Forecasts For Tuesday

Micron, Endeavour Silver, First Majestic Silver, Applied Digital And Other Big Stocks Moving Higher On Friday
benzinga.com
Micron, Endeavour Silver, First Majestic Silver, Applied Digital And Other Big Stocks Moving Higher

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some

benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

This morning 279 companies reached new 52-week highs.
benzinga.com
84 Biggest Movers From Yesterday

Gainers

benzinga.com
60 Stocks Moving In Thursday's Mid-Day Session

Gainers Immutep Limited (NASDAQ: IMMP) shares jumped 198.6% to $6.42 after the company said its C
benzinga.com
60 Biggest Movers From Yesterday

60 Biggest Movers From Yesterday
benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018

Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
benzinga.com
36 Biggest Movers From Friday

36 Biggest Movers From Friday
benzinga.com
30 Stocks Moving In Friday's Mid-Day Session

30 Stocks Moving In Friday's Mid-Day Session